A First-In-Human study to evaluate LFX453 in Healthy Volunteers.

• Research type

  Research Study

• Full title

  A first-in-human study to evaluate the safety, tolerability and pharmacokinetics of LFX453 after multiple topical applications in healthy volunteers.

• IRAS ID

  140936

• Contact name

  Girish Sharma

• Contact email

  girish.sharma@simbec.co.uk

• Sponsor organisation

  Novartis Pharmaceuticals Limited

• Eudract number

  2013-002344-84

• ISRCTN Number

  to be entered

• REC name

  Wales REC 1

• REC reference

  13/WA/0343

• Date of REC Opinion

  27 Nov 2013

• REC opinion

  Further Information Favourable Opinion